Implant Sciences Corporation, a high technology supplier of systems and sensors for homeland security and defense markets, today announced that it has opened a representative office in Shanghai, China.
The new office, which will operate as American Implant Sciences, Shanghai Representative Office, better positions the Company to work closely with its current in-country distributors, identify additional new distributors, and enhance its understanding of the China market. Joseph Laskey, Area Vice President and General Manager, Asian Sales and Business Development, will lead the Shanghai office.
The office is located in the Changning district of Shanghai at Room 521, GIFC No. 1438, Hongqiao Road, Shanghai, China 200021. Shanghai was selected as the location given its status as a global city with influence in commerce, technology and transportation, and its proximity to Nanjing, the second-largest commercial center in China and Hangzhou, China's fourth largest metropolitan area.
"Having generated sales of $20 million to date, China is a very important market for Implant Sciences. We believe that having our own representative office in Shanghai to support our distribution network will help further increase our market share and revenues in the country," stated Implant Sciences' President and CEO, Glenn D. Bolduc.
"This is an opportune time for us to open a representative office. China has implemented a sweeping program to upgrade and outfit the security measures in new and expanded airports throughout the country. Given our track record of sales and a strong word of mouth reputation in the aviation security market in China, this is a significant opportunity for us," commented Dr. Darryl Jones, Vice President Sales and Marketing.
According to reports from the Civil Aviation Administration of China (CAAC), there are approximately 180 airports in China that are now being brought up to international standards, with more under construction. During China's 12th Five-Year Plan period, from 2011 to 2015, 56 new airports are scheduled to be built, 16 relocated and 91 expanded.
Source: http://www.implantsciences.com/